|
|
|
Volumn 8, Issue 11, 2005, Pages 914-918
|
|
Therapeutic switching: A new strategic approach to enhance R&D productivity
|
|
Author keywords
Drug repositioning; Drug reprofiling; Drug repurposing; Therapeutic switching
|
|
Indexed keywords
ALENDRONIC ACID;
AMFEBUTAMONE;
APOMORPHINE;
ATOMOXETINE;
CARBOPLATIN;
CYMBALTAN;
DOXYCYCLINE;
DULOXETINE;
ETODOLAC;
FLUOXETINE;
GABAPENTIN;
GALANTAMINE;
GLYCOPYRRONIUM BROMIDE;
MEMANTINE;
MILNACIPRAN;
MINOXIDIL;
PACLITAXEL;
PAROXETINE;
RALOXIFENE;
ROPINIROLE;
SILDENAFIL;
TADALAFIL;
THALIDOMIDE;
TOFISOPAM;
TOPIRAMATE;
UNCLASSIFIED DRUG;
ALZHEIMER DISEASE;
ARTICLE;
BACTERIAL INFECTION;
BREAST CANCER;
CARDIOVASCULAR DISEASE;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL TRIAL;
DEPRESSION;
DRUG INDICATION;
DRUG MARKETING;
DRUG RESEARCH;
DRUG USE;
EPILEPSY;
ERECTILE DYSFUNCTION;
FACE PAIN;
FIBROMYALGIA;
HEART FAILURE;
HUMAN;
HYPERTENSION;
INSOMNIA;
LEPROSY;
MALE TYPE ALOPECIA;
MULTIPLE MYELOMA;
OSTEOPOROSIS;
PARALYSIS;
PARKINSON DISEASE;
PATENT;
PERIODONTITIS;
POLIOMYELITIS;
SIDE EFFECT;
WASTING SYNDROME;
DRUG DESIGN;
DRUG THERAPY;
EFFICIENCY;
HUMANS;
PATENTS;
|
|
EID: 28044452193
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (16)
|
|
References (6)
|
